METHODS FOR USING ALDHbr CELLS TO SUPPLEMENT STEM CELL TRANSPLANTATION
The present invention relates to methods repairing, regenerating, and reconstituting tissues by transplanting at least two stem cell populations, wherein the first and the second population of stem cells are introduced into a subject separated by a time interval of about 2 to about 24 hours. The first population comprises stem cells derived from umbilical cord. The second population comprises ALDHbr cells. These ALDHbr cells can be administered to a patient immediately after isolation or can be primed in culture using a combination of cytokines for about 2 to about 7 days prior to transplantation. The methods of the invention are useful in accelerating time to neutrophil and/or platelet engraftment and immune reconstitution following myeloablative therapy.
1 . A method of reconstituting blood tissue in a subject in need thereof, said method comprising introducing into said subject a first and a second population of cells derived from umbilical cord blood, wherein said second population of cells is introduced between 2 and 24 hours after the first population of cells, wherein at least the second population is an enriched ALDH br stem cell population.
2 . The method of claim 1 , wherein said second population of cells is introduced about 4 hours after the first population.
3 . The method of claim 1 , wherein the first and second populations of cells are derived from the same cord blood unit or donor.
4 . The method of claim 1 , wherein the first and second populations of cells are derived from different donors.
5 . The method of claim 1 , wherein said subject is in need of hematopoietic reconstitution following bone marrow ablation.
6 . A method of restoring hematologic function following myeloablative treatment in a subject having cancer, said method comprising introducing into said subject a first and a second population of cells, wherein said second population of cells is introduced between 2 and 24 hours after the first population of cells, wherein at least the second population is an enriched ALDH br stem cell population.
7 . The method of claim 6 , wherein said subject is in need of treatment for sequelae related to cancer therapy.
8 . A method for accelerating hematopoietic recovery in a subject following myeloablation comprising introducing into said subject a first and a second population of cells, wherein said second population of cells is introduced between 2 and 24 hours after the first population of cells, and wherein at least the second population is an ALDH br stem cell population.
9 . The method of claim 8 , wherein the time to neutrophil engraftment in the subject is shortened compared to the time to neutrophil engraftment in a control subject.
10 . The method of claim 8 , wherein the time to platelet engraftment is shortened compared to the time to platelet engraftment in a control subject.
11 . A method of restoring hematologic function following myeloablative treatment in a subject having a genetic disorder comprising introducing into said subject a first and a second population of cells, wherein said second population of cells is introduced between 2 and 24 hours after the first population of cells, wherein at least the second population is an enriched ALDH br stem cell population.
12 . A method of restoring bone marrow stem or progentitor cell activity following myeloablative treatment in a subject having cancer comprising introducing into said subject a first and a second population of cells, wherein said second population of cells is introduced between 2 and 24 hours after the first population of cells, wherein at least the second population is an enriched ALDH br stem cell population.
13 . A method of restoring bone marrow stem or progentitor cell activity following myeloablative treatment in a subject having a genetic disorder comprising introducing into said subject a first and a second population of cells, wherein said second population of cells is introduced between 2 and 24 hours after the first population of cells, wherein at least the second population is an enriched ALDH br stem cell population.